Table 3.

Percentage of cell populations in different stages of the cell cycle following exposure to different groups of nanoliposomes for 24 h

Treatment group	G1 phase	S phase	G2 phase
Untreated cells	51.73 ± 1.17	27.00 ± 3.44	21.26 ± 3.41
HRZ	55.13 ± 1.59	27.10 ± 5.93	17.83 ± 3.01
HRZ/siNC	54.06 ± 2.93	26.90 ± 4.38	17.90 ± 2.43
HRZ/siTGF-β1 (35 mg/ml)	46.95 ± 1.15	25.20 ± 3.22	26.84 ± 1.58
HRZ/siTGF-β1 (40 mg/ml)	41.07 ± 1.22	20.37 ± 2.34	38.54 ± 2.02**

The results are presented as the average percentage of the cell population (%) ± standard deviation; P < 0.05*, *P < 0.01 vs. untreated cells